Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression

J. N. Hingtgen, Hugh Hendrie, M. H. Aprison

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule. Data from studies designed to distinguish presynaptic from postsynaptic events, indicated that the antidepressants were acting in part as blockers of postsynaptic serotonergic receptors. Using the same 5-HTP model of depression, we studied both the chronic and acute effects of a recently introduced antidepressant, trazodone, a triazolopyridine compound. Rats working for milk reinforcement and exhibiting behavioral depression following administration of 50 mg/kg 5-HTP were pretreated (one hr before 5-HTP) with 1, 2, or 4 mg/kg trazodone with resulting blockade of 5-HTP induced depression of 35, 62 and 70% respectively. Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75%). Neither 2 mg/kg or 4 mg/kg trazodone was found to potentiate the shorter period of depression following 25 mg/kg 5-HTP. Chronic treatment with the antidepressant drugs, amitriptyline or mianserin also blocked 5-HTP depression. Thus, as in our earlier studies, these data suggest an important postsynaptic mechanism associated with chronic administration of trazodone, amitriptyline and mianserin which could be implicated in the therapeutic effectiveness of these drugs. The potency of trazodone in relation to other antidepressant drugs in our behavioral model of depression paralleled their potency in displacing radioligand binding to 5-HT receptors, and gives additional support for the new hypersensitive postsynaptic serotonin receptor theory of depression.

Original languageEnglish
Pages (from-to)425-428
Number of pages4
JournalPharmacology Biochemistry and Behavior
Volume20
Issue number3
DOIs
StatePublished - 1984

Fingerprint

Trazodone
5-Hydroxytryptophan
Animals
Animal Models
Antidepressive Agents
Mianserin
Amitriptyline
Serotonin Receptors
Rats
Pharmaceutical Preparations
Appointments and Schedules
Reinforcement
Milk
Food

Keywords

  • 5-Hydroxytryptophan
  • Amitriptyline
  • Chronic antidepressant treatment
  • Mianserin
  • Model of depression
  • Postsynaptic
  • Presynaptic
  • Serotonergic receptors
  • Trazodone

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. / Hingtgen, J. N.; Hendrie, Hugh; Aprison, M. H.

In: Pharmacology Biochemistry and Behavior, Vol. 20, No. 3, 1984, p. 425-428.

Research output: Contribution to journalArticle

@article{090b8f72be914c0e998072bc8d9e7861,
title = "Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression",
abstract = "Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule. Data from studies designed to distinguish presynaptic from postsynaptic events, indicated that the antidepressants were acting in part as blockers of postsynaptic serotonergic receptors. Using the same 5-HTP model of depression, we studied both the chronic and acute effects of a recently introduced antidepressant, trazodone, a triazolopyridine compound. Rats working for milk reinforcement and exhibiting behavioral depression following administration of 50 mg/kg 5-HTP were pretreated (one hr before 5-HTP) with 1, 2, or 4 mg/kg trazodone with resulting blockade of 5-HTP induced depression of 35, 62 and 70{\%} respectively. Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75{\%}). Neither 2 mg/kg or 4 mg/kg trazodone was found to potentiate the shorter period of depression following 25 mg/kg 5-HTP. Chronic treatment with the antidepressant drugs, amitriptyline or mianserin also blocked 5-HTP depression. Thus, as in our earlier studies, these data suggest an important postsynaptic mechanism associated with chronic administration of trazodone, amitriptyline and mianserin which could be implicated in the therapeutic effectiveness of these drugs. The potency of trazodone in relation to other antidepressant drugs in our behavioral model of depression paralleled their potency in displacing radioligand binding to 5-HT receptors, and gives additional support for the new hypersensitive postsynaptic serotonin receptor theory of depression.",
keywords = "5-Hydroxytryptophan, Amitriptyline, Chronic antidepressant treatment, Mianserin, Model of depression, Postsynaptic, Presynaptic, Serotonergic receptors, Trazodone",
author = "Hingtgen, {J. N.} and Hugh Hendrie and Aprison, {M. H.}",
year = "1984",
doi = "10.1016/0091-3057(84)90281-8",
language = "English",
volume = "20",
pages = "425--428",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression

AU - Hingtgen, J. N.

AU - Hendrie, Hugh

AU - Aprison, M. H.

PY - 1984

Y1 - 1984

N2 - Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule. Data from studies designed to distinguish presynaptic from postsynaptic events, indicated that the antidepressants were acting in part as blockers of postsynaptic serotonergic receptors. Using the same 5-HTP model of depression, we studied both the chronic and acute effects of a recently introduced antidepressant, trazodone, a triazolopyridine compound. Rats working for milk reinforcement and exhibiting behavioral depression following administration of 50 mg/kg 5-HTP were pretreated (one hr before 5-HTP) with 1, 2, or 4 mg/kg trazodone with resulting blockade of 5-HTP induced depression of 35, 62 and 70% respectively. Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75%). Neither 2 mg/kg or 4 mg/kg trazodone was found to potentiate the shorter period of depression following 25 mg/kg 5-HTP. Chronic treatment with the antidepressant drugs, amitriptyline or mianserin also blocked 5-HTP depression. Thus, as in our earlier studies, these data suggest an important postsynaptic mechanism associated with chronic administration of trazodone, amitriptyline and mianserin which could be implicated in the therapeutic effectiveness of these drugs. The potency of trazodone in relation to other antidepressant drugs in our behavioral model of depression paralleled their potency in displacing radioligand binding to 5-HT receptors, and gives additional support for the new hypersensitive postsynaptic serotonin receptor theory of depression.

AB - Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule. Data from studies designed to distinguish presynaptic from postsynaptic events, indicated that the antidepressants were acting in part as blockers of postsynaptic serotonergic receptors. Using the same 5-HTP model of depression, we studied both the chronic and acute effects of a recently introduced antidepressant, trazodone, a triazolopyridine compound. Rats working for milk reinforcement and exhibiting behavioral depression following administration of 50 mg/kg 5-HTP were pretreated (one hr before 5-HTP) with 1, 2, or 4 mg/kg trazodone with resulting blockade of 5-HTP induced depression of 35, 62 and 70% respectively. Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75%). Neither 2 mg/kg or 4 mg/kg trazodone was found to potentiate the shorter period of depression following 25 mg/kg 5-HTP. Chronic treatment with the antidepressant drugs, amitriptyline or mianserin also blocked 5-HTP depression. Thus, as in our earlier studies, these data suggest an important postsynaptic mechanism associated with chronic administration of trazodone, amitriptyline and mianserin which could be implicated in the therapeutic effectiveness of these drugs. The potency of trazodone in relation to other antidepressant drugs in our behavioral model of depression paralleled their potency in displacing radioligand binding to 5-HT receptors, and gives additional support for the new hypersensitive postsynaptic serotonin receptor theory of depression.

KW - 5-Hydroxytryptophan

KW - Amitriptyline

KW - Chronic antidepressant treatment

KW - Mianserin

KW - Model of depression

KW - Postsynaptic

KW - Presynaptic

KW - Serotonergic receptors

KW - Trazodone

UR - http://www.scopus.com/inward/record.url?scp=0021278709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021278709&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(84)90281-8

DO - 10.1016/0091-3057(84)90281-8

M3 - Article

C2 - 6608737

AN - SCOPUS:0021278709

VL - 20

SP - 425

EP - 428

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -